NovoCure Ltd — Director's Dealing 2016

May 6, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Novocure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2016-05-04

Reporting Person: Perlhagen Gert L. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-05-04	Options to Buy Ordinary Shares	$11.39	A	21500	Acquired	2026-05-04	Ordinary Shares (21500)	Direct

Footnotes

F1: Options to buy 21,500 ordinary shares will fully vest and become exercisable on May 4, 2017, subject to Mr. Perlhagen serving as a Director through such date.